Ketamine-induced behavioral perturbations, redox imbalances, and neurotransmitter deficits in mice: The preventive and reversal neuromodulatory potential of diosmin as an antipsychotic
Schizophrenia is a major neuropsychiatric disorder associated with neurochemical perturbations characterized by behavioral abnormalities, for which effective treatment remains elusive. The current study investigated the neurotransmitter modulatory effect of diosmin in preventing and reversing ketami...
Saved in:
| Main Authors: | Aya-Ebi Okubo Eneni, Benneth Ben-Azu, Abayomi Mayowa Ajayi, Adegbuyi Oladele Aderibibge |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Brain Disorders |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666459325000307 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The impact of pimavanserin on psychotic phenotypes and tau phosphorylation in the P301L/COMT– and rTg(P301L)4510 mouse models of Alzheimer's disease
by: Heidy Jimenez, et al.
Published: (2022-01-01) -
Ketamine for rapid control of hyperactive delirium with severe agitation. A retrospective comparison study
by: Beatrice Borreani, et al.
Published: (2025-03-01) -
Metformin in the management of antipsychotic-induced weight gain – why the ‘weight’?
by: Ita Fitzgerald, et al.
Published: (2024-11-01) -
Latest findings challenge behavioural approaches to the management of antipsychotic-induced weight gain
by: Steve Kisely, et al.
Published: (2025-05-01) -
Case Report: Lewy body dementia with unusual psychotic symptoms, atypically late parkinsonism, and patient sensitivity to first generation antipsychotics
by: Lolita Ercika, et al.
Published: (2025-04-01)